Therapeutic options for patients who fail on metformin include the addition of a sulfonylurea, the addition of a thiazolidinediones or the addition of insulin, and the risks associated with these therapies include hypoglycemia, weight gain, fluid retention, worsening heart failure or lipid profiles, which limits their usefulness.
基于1个网页-相关网页
应用推荐